EVP R&D, Chief Medical Officer
Mon, Feb 2, 2026
Feb 2
4,000 shares @ $33.54
Decreased holdings by -6.50%
46th largest trade (out of 157)
Planned (10b5-1)
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 18% above 200-day moving average